Gilead Share Price
NASDAQ: GILD | Mega Cap | HealthcareGilead Stock Performance
Gilead Share Price Today
As of 19 November 2026, Gilead Sciences, Inc.'s share price is $169.27. The stock opened at $167.91, compared to its previous close of $170.25. During today's trading session, Gilead Sciences, Inc.'s share price traded between $167.84 and $170.48, with an average price of $169.16. Over the past 52 weeks, the stock has recorded a high of $176.56 and a low of $116.93. In terms of performance, Gilead Sciences, Inc.'s share price has risen by 25.89% over the last six months and is up 34.50% on a year-on-year basis.
Gilead Share Price Chart
Gilead Quarterly Profit & Loss
All figures in USD
Gilead Annual Profit & Loss
All figures in USD
Gilead Balance Sheet
All figures in USD Billion
Gilead Cash Flow
Corporate Actions
About Gilead
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Gilead Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $169.51 | $169.28 | -0.83% |
Oct 2026 | $149.44 | $170.70 | +14.41% |
Sep 2026 | $147.87 | $149.19 | +0.24% |
Aug 2026 | $131.20 | $148.84 | +14.33% |
Jul 2026 | $127.19 | $130.19 | +3.13% |
Jun 2026 | $133.43 | $126.24 | -6.11% |
May 2026 | $130.16 | $134.46 | +2.76% |
Apr 2026 | $139.01 | $130.84 | -6.10% |
Mar 2026 | $147.87 | $139.35 | -6.46% |
Feb 2026 | $141.26 | $148.97 | +4.92% |
Jan 2026 | $122.41 | $141.98 | +15.65% |
Dec 2025 | $125.84 | $122.77 | -2.46% |








